DIETHYL_2-[(((3-(N-ACETYL)-AMINO)-3-(BISETHOXYCARBONYL)-PROPYL)-(ETHOXY)-PHOSPHINYL]-BUTAN-1,4-DIOATE;ISOMER_2
Compound with spectra: 1 NMR
![DIETHYL_2-[(((3-(N-ACETYL)-AMINO)-3-(BISETHOXYCARBONYL)-PROPYL)-(ETHOXY)-PHOSPHINYL]-BUTAN-1,4-DIOATE;ISOMER_2](/api/compound/63YUPYoVlgu.png?ph=true&h=300&w=458 "DIETHYL_2-[(((3-(N-ACETYL)-AMINO)-3-(BISETHOXYCARBONYL)-PROPYL)-(ETHOXY)-PHOSPHINYL]-BUTAN-1,4-DIOATE;ISOMER_2")
| SpectraBase Compound ID | 63YUPYoVlgu |
|---|---|
| InChI | InChI=1S/C21H36NO11P/c1-7-22(27)21(19(25)31-10-4,20(26)32-11-5)13-14-34(28,33-12-6)16(18(24)30-9-3)15-17(23)29-8-2/h7,16H,8-15H2,1-6H3/b22-7- |
| InChIKey | OUQRIGOSBLFSFC-HOEBFWFUSA-N |
| Mol Weight | 509.5 g/mol |
| Molecular Formula | C21H36NO11P |
| Exact Mass | 509.202598 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
ETHYL-2-(DIETHOXYPHOSPHORYL)-4,5,6,7-TETRABROMO-INDANE-2-CARBOXYLATE
3-(3-chloro-1H-1,2,4-triazol-1-yl)-N-(2-fluoro-5-methylphenyl)-1-adamantanecarboxamide
1H-pyrazole-3,5-dicarboxylic acid, 4-amino-1-(3-chlorophenyl)-, diethyl ester
(2S,6R,1'R,3'R)-2-(3'-BENZYLOXY-1'-DIPHENYLPHOSPHINOYLHEPTYL)-6-HYDROXY-3,6-DIHYDRO-2H-PYRAN-3-ONE
(2S,6S,1'R,3'R)-2-(3'-BENZYLOXY-1'-DIPHENYLPHOSPHINOYLHEPTYL)-6-HYDROXY-3,6-DIHYDRO-2H-PYRAN-3-ONE
(R,R,R,S,S,S)-3-PHENYL-2-[[1'-(BENZYLOXYCARBONYL)-AMINO-2'-PHENYLETHYL]-METHYLOXYPHOSPHINYL]-PROPANOIC-ACID-TERT.-BUTYLESTER
acetic acid, [[5-(3,4-dimethoxyphenyl)-4-phenyl-4H-1,2,4-triazol-3-yl]thio]-, 2-[(E)-(5-bromo-2-fluorophenyl)methylidene]hydrazide
Glutamyl-histidyl-tryptophyl-seryl-tyrosyl-glycine
1.alpha.-(4-Hydroxybutoxy)-2.beta.,25-dihydroxy-2.alpha.-methyl-19-norvitamin D3
isoxazolo[5,4-b]pyridine, 6-(1,3-benzodioxol-5-yl)-4-(difluoromethyl)-3-methyl-
| Title | Journal or Book | Year |
|---|---|---|
| A Virtual Screening Hit Reveals New Possibilities for Developing Group III Metabotropic Glutamate Receptor Agonists | Journal of Medicinal Chemistry | 2010 |